Rosetta Genomics Ltd. (OTCPK: ROSG.Q)
Health Care · Biotechnology · IL
$—
— today · — 1Y
Rosetta Genomics Ltd. (OTCPK: ROSG.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $593.00.
trading between 0.00 and 0.00.
Tweenvest scores Rosetta Genomics Ltd. across four factors: quality 34/100, value 51/100, growth 100/100. Its strongest factor is growth.
ROSG.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $593.00
- Revenue (TTM)
- $2.86M
- P/E
- —
- EPS
- -6.41
- Dividend yield
- —
- Beta (5Y)
- 62.33
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.93M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc.OTCPK: EFTR | $941.00 | $0.00 | -75.00% |
| Proteonomix, Inc.OTCPK: PROT | $791.00 | $— | — |
| Pathfinder Cell Therapy, Inc.OTCPK: PFND | $667.00 | $— | — |
| Amarantus BioScience Holdings, Inc.OTCPK: AMBS | $630.00 | $0.00 | — |
| Adynxx, Inc.OTCPK: ADYX | $581.00 | $— | — |
| GlobeImmune, Inc.OTCPK: GBIM | $575.00 | $0.00 | — |
| Manhattan Scientifics, Inc.OTCPK: MHTX | $559.00 | $0.00 | -99.00% |
| Mera Pharmaceuticals, Inc.OTCPK: MRPI | $537.00 | $— | — |
Figures last refreshed Oct 4, 2026.